Peter Sandercock and IST-3
A Science podcast
Peter Sandercock and IST-3
About
Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischemic stroke within 3 hours of symptom onset. The International Stroke Trial or IST-3 seeks to determine whether a wider range of patients may benefit the International Journal of Stroke spoke to chief investigator Dr Peter Sandercock.
Show More
Creators & Guests
Podcast Reviews
Mentioned In These Lists
Host or manage this podcast?
Do you host or manage this podcast?
Claim and edit this page to your liking.
Claim and edit this page to your liking.
Are we missing an episode or update?
Use this to check the RSS feed immediately.
Use this to check the RSS feed immediately.
Podcast Details
Created by
wiley-blackwell
Podcast Status
Idle
Started
Aug 17th, 2010
Latest Episode
Aug 17th, 2010Episodes
1
Avg. Episode Length
13 minutes
Explicit
No
Language
English
- Podcasts
- Best Podcasts
- New Podcasts
- Podcast Charts
- Best Episodes
- Add a Podcast
- Claim a Podcast
- Podchaser 25
- Features
- Podcast Credits
- Podcast Networks
- Podcast Lists
- Podcast Monitoring
- Podcast Sponsors
- Podcast Contacts
- Community
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Newsletter
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2025 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us